As head of R&D at Novo Nordisk, Marcus Schindler is leading the company’s efforts to embrace external innovation and expand into new therapeutic areas with AI as a powerful catalyst for progress.
Source: McKinsey

Advancing R&D for chronic diseases with AI: A conversation with Novo Nordisk’s CSO